- AstraZeneca and Merck in $8.5-billion oncology deal 27 July 2017
- Merck calls off late-stage trial of Alzheimer's drug verubecestat 15 February 2017
- Merck wins $2.54 bn in royalties in patent lawsuit 16 December 2016
- Merck & Co and Allergan eye US biotechnology company Biogen 03 August 2016
- Merck gets a $5-mn Ebola vaccine shot from Vaccine Alliance 22 January 2016
- Merck & Co to buy Cubist Pharmaceuticals for $8.4 bn 10 December 2014
- Merck & Co to buy back $5-bn worth stock 22 May 2013
- Merck & Co forecast profit decline for 2013 02 February 2013
- Merck to recall good HDL cholesterol drug Tredaptive 12 January 2013
- Merck, Brazil's Supera Farma to form JV for generic drugs 16 February 2012
- Merck to pay $950 million to settle Vioxx drug charges 24 November 2011
- Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million 29 September 2011
- Merck & Co to axe 13,000 more jobs by 2015 30 July 2011
- Sun to co market Merck's Diabetes drugs in India 25 April 2011
- Merck, Sun Pharma in generics JV 11 April 2011
- Merck hopes to be among top-five drugmakers in India 11 March 2011
- Merck and Ranbaxy end drug development pact 06 January 2011
- Merck aims for top slots in seven emerging markets 15 November 2010
- Merck settles Zetia patent suit with Glenmark 11 May 2010
- Merck receives EC approval for infertility treatment drug Elnova 28 January 2010
- Merck wins summary judgment in Vioxx lawsuit in Texas 23 November 2009
- Merck receives FDA approval for new fertility drug for women 21 November 2009
- Merck & Co gets exclusive US rights for Afluria from CSL Biotherapies 29 September 2009
- Merck, Wellcome Trust tie up to make affordable drugs in India 19 September 2009
- Judge declares mistrial in Merck's Fosamax case 12 September 2009
- Merck wins court ruling on Singulair patent 20 August 2009
- Merck, Schering-Plough shareholders approve $41-billion deal 10 August 2009
- Merck's Q2 profit falls, but beats expectations 22 July 2009
- Ranbaxy to develop new drugs for Merck & Co 10 May 2008
- US FDA turns down Merck's ER niacin / laropiprant 29 April 2008
- Shasun Chemicals technology licenses API technology to Merck 27 February 2008
- Nicholas Piramal in R&D collaboration with Merck & Co 19 November 2007
- Merck agrees to settle Vioxx claims for $4.85 billion 15 November 2007
- Merck suffers adverse Vioxx lawsuit in the US 13 March 2007
- Dr Reddy's to join the race for Merck's generic business 05 February 2007
- Tata Group''s Advinus to develop metabolic drugs for Merck 16 November 2006
- Merck & Co develops new diabetes drug 14 June 2006
- Merck wins second Vioxx lawsuit 18 February 2006
- Dr Reddy's Laboratories enters into agreement with Merck 01 February 2006
- Merck, ICMR to conduct joint trials on cervical cancer vaccine 22 December 2005
- Merck antifungal drug faces key U.S. panel test 16 February 2001
